399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer
oleh: William Redmond, Walter Urba, Yoshinobu Koguchi, David Page, Maritza Martel, Staci Mellinger, Ayca Gucalp, Zhaoyu Sun, Yaping Wu, Brie Chun, Krystle Collins, Nicole Moxon, Tiffany Traina
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.